Abstract
Background A growing body of literature suggests that music medicine may decrease anxiety and depression in cancer patients, but the mechanism by which this happens remains speculative. This study analyzes the underlying thematic perspectives by utilizing both quantitative and qualitative assessments. Therefore, the goal of this study is to determine the quantitative effects and underlying thematic perspectives of music medicine on anxiety and depression in cancer inpatients.
Methods and findings Twenty-four cancer inpatients participated in this prospective cohort study to measure the effects of a private, fifteen-minute, live guitar/singing performance on anxiety and depression. Questions modified from the Hospital Anxiety and Depression Scale (HADS) and a written free response section were used. Independent from age, gender, and relationship to music, music medicine significantly increased patients’ cheerfulness, ability to laugh, relaxation, and decreased worrying thoughts. There was also a trend towards decreased tension, restlessness, feeling slowed down, and increased excitement for the future that failed to reach statistical significance. The most frequently used words within the free response sections were made into a word cloud with the three most common words being music, listening, and made.
Conclusion This article not only illustrates that music medicine decreases several elements of anxiety and depression in cancer inpatients, but also highlights music’s physiological effects, aesthetic and potentially transcendent properties, intrinsic value, and memorability, through use of a word cloud. Music medicine is a safe and inexpensive mood augmenter that could be more widely used.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ISRCTN28383230
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study, protocol 21-014, was approved by the Institutional Review Board (IRB) and Human Research Protection Program (HRPP) of Cooper University Hospital and MD Anderson Cancer Center.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data may be found in the attached spreadsheet labeled "S1 supporting information".
